Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy
Abstract Breast cancer, the most prevalent malignancy among women, frequently exhibits high HER2 expression, making HER2 a critical therapeutic target. Traditional treatments combining the anti‐HER2 antibody trastuzumab with immunotherapy face limitations due to toxicity and tumor microenvironment i...
Saved in:
Main Authors: | Changyong Guo, Fei Gao, Guoyuan Wu, Jinqiu Li, Chunquan Sheng, Shipeng He, Honggang Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202410778 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discussion on the mechanism of HER2 resistance in esophagogastric junction and gastric cancer in the era of immunotherapy
by: Yan Zhang, et al.
Published: (2025-12-01) -
Photodynamic therapy for the precise treatment of localized prostate cancer
by: Youcheng Xu, et al.
Published: (2025-02-01) -
Single component organic photosensitizer for tumor Photodynamic/Photothermal immunotherapy via apoptosis and pyroptosis
by: Miao-Yan Xu, et al.
Published: (2025-03-01) -
A Review of Plastic Pollution; Conventional and Recent Bioremediation Technologies
by: Chinedum Chukwuemeka Udekwu, et al.
Published: (2024-06-01) -
Impact of HER2-targeting antibody drug conjugates in treatment strategies for patients with breast cancer
by: Hanghang Ma, et al.
Published: (2025-02-01)